Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells1

Xiao Feng Li(Rosie Hospital), D. Stephen Charnock‐Jones(Rosie Hospital), Eko Zhang(Rosie Hospital), Susan E. Hiby(MRC Human Nutrition Research), Shazia Malik(Rosie Hospital), Kate Day(Rosie Hospital), D Licence(Rosie Hospital), Joanne Bowen(MRC Human Nutrition Research), Lucy Gardner(MRC Human Nutrition Research), Ashley King(MRC Human Nutrition Research), Y.W. Loke(MRC Human Nutrition Research), S. K. Smith(Rosie Hospital)
The Journal of Clinical Endocrinology & Metabolism
April 1, 2001
Cited by 303Open Access
Full Text

Abstract

Angiogenesis is essential for endometrial growth and repair, and disruption of this process may lead to common disorders of women, including menorrhagia and endometriosis. In pregnancy, failure of the endometrial spiral arterioles to undergo remodeling leads to preeclampsia. Here we report that in addition to vascular endothelial growth factor A (VEGF-A), human endometrium expresses messenger ribonucleic acids (mRNAs) encoding VEGF-C, placenta growth factor (PlGF), the angiopoietins, angiopoietin 1 (Ang1) and Ang2, and the receptors VEGFR-3 (Flt-4), Tie 1, and Tie 2. Levels of VEGF-C, PlGF, and Tie 2 changed during the menstrual cycle. Intense hybridization for VEGF-C and PlGF mRNAs was found in uterine nature killer cells in secretory phase endometrium and for Ang2 mRNA in the same cells in the late secretory phase. Interleukin-2 (IL-2) and IL-15 up-regulated VEGF-C, but not PlGF or Ang2, mRNA levels in isolated NK cells. Conditioned medium from decidual NK cells did not induce human umbilical vein endothelial cell apoptosis. These results indicate that human endometrium expresses a wide range of angiogenic growth factors and that uterine nature killer cells may play an important role in the abnormal endometrial angiogenesis that underlies a range of disorders affecting women.


Related Papers

No related papers found

Powered by citation graph analysis